Related Experiment Video
Updated: May 12, 2026

04:33
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
Published on: December 8, 2023
Aptamer Regulated NIR Carbon Dot/AuNP Fluorescence Sensing Platform for Selective Sarcosine Detection
Haiyin Huang1, Shuping Zhou1, Mei Yang1
1Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518060, P.R. China.
Journal of Fluorescence
|May 11, 2026
Summary
A novel near-infrared fluorescence sensor using carbon dots and gold nanoparticles detects prostate cancer biomarker sarcosine. This aptamer-regulated system offers sensitive and selective sarcosine detection for early diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Sarcosine (SA) is a potential prostate cancer biomarker.
- Accurate detection of sarcosine is crucial for early diagnosis and treatment monitoring.
- Existing detection methods may lack sensitivity, selectivity, or require complex procedures.
Purpose of the Study:
- To develop a sensitive and selective near-infrared (NIR) fluorescence sensing platform for sarcosine detection.
- To utilize NIR carbon dots (CDs), gold nanoparticles (AuNPs), and sarcosine-specific aptamers (SA-Apt) for this purpose.
- To establish an aptamer-regulated inner filter effect (IFE) based sensing mechanism.
Main Methods:
- Synthesized nitrogen- and sulfur-co-doped NIR-CDs using a solvothermal method.
- Prepared AuNPs via a citrate-reduction approach.
- Developed a sensing mechanism based on SA-Apt binding to SA, leading to AuNP aggregation and NIR-CD fluorescence quenching via IFE.
Main Results:
- The NIR-CDs/AuNPs/SA-Apt platform showed a linear response to sarcosine from 1-15 µM (R²=0.996).
- Achieved a limit of detection of 0.32 µM (S/N=3) with high selectivity and reproducibility.
- Demonstrated stable NIR fluorescence performance and effective sarcosine quantification.
Conclusions:
- The developed aptamer-regulated IFE sensing platform provides a robust, non-enzymatic strategy for sensitive and selective sarcosine detection.
- This approach holds promise for the early diagnosis of prostate cancer.
- Integration of NIR-CDs and AuNPs enhances sensing performance, offering a valuable tool in biomarker detection.
